Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Non-trigeminal nociceptive innervation of the posterior dura: implications to occipital headache.

Noseda R, Melo-Carrillo A, Nir RR, Strassman AM, Burstein R.

J Neurosci. 2019 Jan 8. pii: 2153-18. doi: 10.1523/JNEUROSCI.2153-18.2018. [Epub ahead of print]

PMID:
30622169
2.

Development and validation of a new method for indirect estimation of neonatal, infant, and child mortality trends using summary birth histories.

Burstein R, Wang H, Reiner RC Jr, Hay SI.

PLoS Med. 2018 Oct 31;15(10):e1002687. doi: 10.1371/journal.pmed.1002687. eCollection 2018 Oct.

3.

The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theory.

Bernstein CA, Nir RR, Noseda R, Fulton AB, Huntington S, Lee AJ, Bertisch SM, Hovaguimian A, Buettner C, Borsook D, Burstein R.

Pain. 2018 Oct 29. doi: 10.1097/j.pain.0000000000001434. [Epub ahead of print]

PMID:
30376534
4.

Variation in Childhood Diarrheal Morbidity and Mortality in Africa, 2000-2015.

Reiner RC Jr, Graetz N, Casey DC, Troeger C, Garcia GM, Mosser JF, Deshpande A, Swartz SJ, Ray SE, Blacker BF, Rao PC, Osgood-Zimmerman A, Burstein R, Pigott DM, Davis IM, Letourneau ID, Earl L, Ross JM, Khalil IA, Farag TH, Brady OJ, Kraemer MUG, Smith DL, Bhatt S, Weiss DJ, Gething PW, Kassebaum NJ, Mokdad AH, Murray CJL, Hay SI.

N Engl J Med. 2018 Sep 20;379(12):1128-1138. doi: 10.1056/NEJMoa1716766.

5.

Tracking patients with chronic occipital headache after occipital nerve decompression surgery: A case series.

Blake P, Nir RR, Perry CJ, Burstein R.

Cephalalgia. 2018 Sep 14:333102418801585. doi: 10.1177/0333102418801585. [Epub ahead of print]

PMID:
30217120
6.

The association between migraine and hospital readmission due to pain after surgery: A hospital registry study.

Platzbecker K, Zhang MB, Kurth T, Rudolph MI, Eikermann-Haerter K, Burstein R, Eikermann M, Houle T.

Cephalalgia. 2018 Jan 1:333102418786457. doi: 10.1177/0333102418786457. [Epub ahead of print]

PMID:
29984600
7.

Current understanding of photophobia, visual networks and headaches.

Noseda R, Copenhagen D, Burstein R.

Cephalalgia. 2018 Jan 1:333102418784750. doi: 10.1177/0333102418784750. [Epub ahead of print]

PMID:
29940781
8.

Color-selective photophobia in ictal vs interictal migraineurs and in healthy controls.

Nir RR, Lee AJ, Huntington S, Noseda R, Bernstein CA, Fulton AB, Bertisch SM, Hovaguimian A, Buettner C, Borsook D, Burstein R.

Pain. 2018 Oct;159(10):2030-2034. doi: 10.1097/j.pain.0000000000001303.

PMID:
29905657
9.

Mapping child growth failure in Africa between 2000 and 2015.

Osgood-Zimmerman A, Millear AI, Stubbs RW, Shields C, Pickering BV, Earl L, Graetz N, Kinyoki DK, Ray SE, Bhatt S, Browne AJ, Burstein R, Cameron E, Casey DC, Deshpande A, Fullman N, Gething PW, Gibson HS, Henry NJ, Herrero M, Krause LK, Letourneau ID, Levine AJ, Liu PY, Longbottom J, Mayala BK, Mosser JF, Noor AM, Pigott DM, Piwoz EG, Rao P, Rawat R, Reiner RC, Smith DL, Weiss DJ, Wiens KE, Mokdad AH, Lim SS, Murray CJL, Kassebaum NJ, Hay SI.

Nature. 2018 Feb 28;555(7694):41-47. doi: 10.1038/nature25760.

10.

Mapping local variation in educational attainment across Africa.

Graetz N, Friedman J, Osgood-Zimmerman A, Burstein R, Biehl MH, Shields C, Mosser JF, Casey DC, Deshpande A, Earl L, Reiner RC, Ray SE, Fullman N, Levine AJ, Stubbs RW, Mayala BK, Longbottom J, Browne AJ, Bhatt S, Weiss DJ, Gething PW, Mokdad AH, Lim SS, Murray CJL, Gakidou E, Hay SI.

Nature. 2018 Feb 28;555(7694):48-53. doi: 10.1038/nature25761.

11.

Responsivity of Periaqueductal Gray Connectivity Is Related to Headache Frequency in Episodic Migraine.

Solstrand Dahlberg L, Linnman CN, Lee D, Burstein R, Becerra L, Borsook D.

Front Neurol. 2018 Feb 13;9:61. doi: 10.3389/fneur.2018.00061. eCollection 2018.

12.

Activation of pial and dural macrophages and dendritic cells by cortical spreading depression.

Schain AJ, Melo-Carrillo A, Borsook D, Grutzendler J, Strassman AM, Burstein R.

Ann Neurol. 2018 Mar;83(3):508-521. doi: 10.1002/ana.25169. Epub 2018 Mar 13.

PMID:
29394508
13.

Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis.

Pigott DM, Deshpande A, Letourneau I, Morozoff C, Reiner RC Jr, Kraemer MUG, Brent SE, Bogoch II, Khan K, Biehl MH, Burstein R, Earl L, Fullman N, Messina JP, Mylne AQN, Moyes CL, Shearer FM, Bhatt S, Brady OJ, Gething PW, Weiss DJ, Tatem AJ, Caley L, De Groeve T, Vernaccini L, Golding N, Horby P, Kuhn JH, Laney SJ, Ng E, Piot P, Sankoh O, Murray CJL, Hay SI.

Lancet. 2017 Dec 16;390(10113):2662-2672. doi: 10.1016/S0140-6736(17)32092-5. Epub 2017 Oct 12.

14.

Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.

Melo-Carrillo A, Strassman AM, Nir RR, Schain AJ, Noseda R, Stratton J, Burstein R.

J Neurosci. 2017 Nov 1;37(44):10587-10596. doi: 10.1523/JNEUROSCI.2211-17.2017. Epub 2017 Sep 29.

15.

Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline analysis for the Sustainable Development Goals.

Golding N, Burstein R, Longbottom J, Browne AJ, Fullman N, Osgood-Zimmerman A, Earl L, Bhatt S, Cameron E, Casey DC, Dwyer-Lindgren L, Farag TH, Flaxman AD, Fraser MS, Gething PW, Gibson HS, Graetz N, Krause LK, Kulikoff XR, Lim SS, Mappin B, Morozoff C, Reiner RC Jr, Sligar A, Smith DL, Wang H, Weiss DJ, Murray CJL, Moyes CL, Hay SI.

Lancet. 2017 Nov 11;390(10108):2171-2182. doi: 10.1016/S0140-6736(17)31758-0. Epub 2017 Sep 25. Review.

16.

The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda.

Wollum A, Dansereau E, Fullman N, Achan J, Bannon KA, Burstein R, Conner RO, DeCenso B, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Masters SH, Njuguna P, Okiro EA, Odeny TA, Allen Roberts D, Gakidou E, Duber HC.

BMC Health Serv Res. 2017 Aug 16;17(1):564. doi: 10.1186/s12913-017-2512-9.

17.

Neural mechanism for hypothalamic-mediated autonomic responses to light during migraine.

Noseda R, Lee AJ, Nir RR, Bernstein CA, Kainz VM, Bertisch SM, Buettner C, Borsook D, Burstein R.

Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5683-E5692. doi: 10.1073/pnas.1708361114. Epub 2017 Jun 26.

18.

Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.

Melo-Carrillo A, Noseda R, Nir RR, Schain AJ, Stratton J, Strassman AM, Burstein R.

J Neurosci. 2017 Jul 26;37(30):7149-7163. doi: 10.1523/JNEUROSCI.0576-17.2017. Epub 2017 Jun 22.

19.

Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.

Lipton RB, Munjal S, Buse DC, Bennett A, Fanning KM, Burstein R, Reed ML.

Headache. 2017 Jul;57(7):1026-1040. doi: 10.1111/head.13115. Epub 2017 Jun 11.

PMID:
28603893
20.

In child and adult migraineurs the somatosensory cortex stands out … again: An arterial spin labeling investigation.

Youssef AM, Ludwick A, Wilcox SL, Lebel A, Peng K, Colon E, Danehy A, Burstein R, Becerra L, Borsook D.

Hum Brain Mapp. 2017 Aug;38(8):4078-4087. doi: 10.1002/hbm.23649. Epub 2017 May 31.

21.

Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache.

Noseda R, Borsook D, Burstein R.

Headache. 2017 May;57 Suppl 2:97-111. doi: 10.1111/head.13083. Review.

22.

Extracranial origin of headache.

Burstein R, Blake P, Schain A, Perry C.

Curr Opin Neurol. 2017 Jun;30(3):263-271. doi: 10.1097/WCO.0000000000000437. Review.

23.

Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.

Buettner C, Melo-Carrillo A, Burstein R.

Headache. 2017 Mar;57(3):478-486. doi: 10.1111/head.13031. No abstract available.

PMID:
28225188
24.

Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache.

Schain AJ, Melo-Carrillo A, Strassman AM, Burstein R.

J Neurosci. 2017 Mar 15;37(11):2904-2915. doi: 10.1523/JNEUROSCI.3390-16.2017. Epub 2017 Feb 13.

25.

Brain network alterations in the inflammatory soup animal model of migraine.

Becerra L, Bishop J, Barmettler G, Kainz V, Burstein R, Borsook D.

Brain Res. 2017 Apr 1;1660:36-46. doi: 10.1016/j.brainres.2017.02.001. Epub 2017 Feb 3.

26.

Cortico-Cortical Connections of Primary Sensory Areas and Associated Symptoms in Migraine.

Hodkinson DJ, Veggeberg R, Kucyi A, van Dijk KR, Wilcox SL, Scrivani SJ, Burstein R, Becerra L, Borsook D.

eNeuro. 2017 Jan 17;3(6). pii: ENEURO.0163-16.2016. doi: 10.1523/ENEURO.0163-16.2016. eCollection 2016 Nov-Dec.

27.

Reply: Pupil area and photopigment spectral sensitivity are relevant to study of migraine photophobia.

Burstein R.

Brain. 2017 Jan;140(1):e3. doi: 10.1093/brain/aww275. Epub 2016 Nov 15. No abstract available.

28.

The Insula: A "Hub of Activity" in Migraine.

Borsook D, Veggeberg R, Erpelding N, Borra R, Linnman C, Burstein R, Becerra L.

Neuroscientist. 2016 Dec;22(6):632-652. Epub 2015 Aug 19. Review.

29.

Brain Changes in Responders vs. Non-Responders in Chronic Migraine: Markers of Disease Reversal.

Hubbard CS, Becerra L, Smith JH, DeLange JM, Smith RM, Black DF, Welker KM, Burstein R, Cutrer FM, Borsook D.

Front Hum Neurosci. 2016 Oct 6;10:497. eCollection 2016.

30.

Increased Functional Activation of Limbic Brain Regions during Negative Emotional Processing in Migraine.

Wilcox SL, Veggeberg R, Lemme J, Hodkinson DJ, Scrivani S, Burstein R, Becerra L, Borsook D.

Front Hum Neurosci. 2016 Jul 26;10:366. doi: 10.3389/fnhum.2016.00366. eCollection 2016.

31.

Increased Amplitude of Thalamocortical Low-Frequency Oscillations in Patients with Migraine.

Hodkinson DJ, Wilcox SL, Veggeberg R, Noseda R, Burstein R, Borsook D, Becerra L.

J Neurosci. 2016 Jul 27;36(30):8026-36. doi: 10.1523/JNEUROSCI.1038-16.2016.

32.

The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia.

Di Giorgio L, Moses MW, Fullman N, Wollum A, Conner RO, Achan J, Achoki T, Bannon KA, Burstein R, Dansereau E, DeCenso B, Delwiche K, Duber HC, Gakidou E, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Maboshe M, Masiye F, Masters SH, Mphuka C, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Murray CJ, Flaxman AD.

BMC Med. 2016 Jul 20;14(1):108. doi: 10.1186/s12916-016-0653-z.

33.

Migraine photophobia originating in cone-driven retinal pathways.

Noseda R, Bernstein CA, Nir RR, Lee AJ, Fulton AB, Bertisch SM, Hovaguimian A, Cestari DM, Saavedra-Walker R, Borsook D, Doran BL, Buettner C, Burstein R.

Brain. 2016 Jul;139(Pt 7):1971-86. doi: 10.1093/brain/aww119. Epub 2016 May 17.

34.

A 'complex' of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients.

Becerra L, Veggeberg R, Prescot A, Jensen JE, Renshaw P, Scrivani S, Spierings ELH, Burstein R, Borsook D.

Neuroimage Clin. 2016 Mar 31;11:588-594. doi: 10.1016/j.nicl.2016.03.020. eCollection 2016.

35.

Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache.

Perry CJ, Blake P, Buettner C, Papavassiliou E, Schain AJ, Bhasin MK, Burstein R.

Ann Neurol. 2016 Jun;79(6):1000-13. doi: 10.1002/ana.24665. Epub 2016 May 5.

36.
37.

Patient satisfaction and perceived quality of care: evidence from a cross-sectional national exit survey of HIV and non-HIV service users in Zambia.

Dansereau E, Masiye F, Gakidou E, Masters SH, Burstein R, Kumar S.

BMJ Open. 2015 Dec 30;5(12):e009700. doi: 10.1136/bmjopen-2015-009700.

38.

Estimating distributions of health state severity for the global burden of disease study.

Burstein R, Fleming T, Haagsma J, Salomon JA, Vos T, Murray CJ.

Popul Health Metr. 2015 Nov 18;13:31. doi: 10.1186/s12963-015-0064-y. eCollection 2015.

39.

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

Bigal ME, Dodick DW, Rapoport AM, Silberstein SD, Ma Y, Yang R, Loupe PS, Burstein R, Newman LC, Lipton RB.

Lancet Neurol. 2015 Nov;14(11):1081-90. doi: 10.1016/S1474-4422(15)00249-5. Epub 2015 Sep 30.

PMID:
26432182
40.

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

Bigal ME, Edvinsson L, Rapoport AM, Lipton RB, Spierings EL, Diener HC, Burstein R, Loupe PS, Ma Y, Yang R, Silberstein SD.

Lancet Neurol. 2015 Nov;14(11):1091-100. doi: 10.1016/S1474-4422(15)00245-8. Epub 2015 Sep 30.

PMID:
26432181
41.

Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial.

Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA, Burstein R.

Ann Neurol. 2015 Dec;78(6):970-81. doi: 10.1002/ana.24534. Epub 2015 Nov 13.

42.

Primary Somatosensory Cortices Contain Altered Patterns of Regional Cerebral Blood Flow in the Interictal Phase of Migraine.

Hodkinson DJ, Veggeberg R, Wilcox SL, Scrivani S, Burstein R, Becerra L, Borsook D.

PLoS One. 2015 Sep 15;10(9):e0137971. doi: 10.1371/journal.pone.0137971. eCollection 2015.

43.
44.

Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda.

Dansereau E, Gakidou E, Ng M, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masters SH, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Duber HC.

PLoS One. 2015 Aug 14;10(8):e0135653. doi: 10.1371/journal.pone.0135653. eCollection 2015.

45.

The migraine brain in transition: girls vs boys.

Faria V, Erpelding N, Lebel A, Johnson A, Wolff R, Fair D, Burstein R, Becerra L, Borsook D.

Pain. 2015 Nov;156(11):2212-21. doi: 10.1097/j.pain.0000000000000292.

PMID:
26172552
46.

Migraine: multiple processes, complex pathophysiology.

Burstein R, Noseda R, Borsook D.

J Neurosci. 2015 Apr 29;35(17):6619-29. doi: 10.1523/JNEUROSCI.0373-15.2015. Review.

47.

Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.

Duber HC, Dansereau E, Masters SH, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masiye F, Njuguna P, Odeny T, Okiro E, Roberts DA, Gakidou E.

PLoS One. 2015 Mar 25;10(3):e0120350. doi: 10.1371/journal.pone.0120350. eCollection 2015.

48.

Female migraineurs show lack of insular thinning with age.

Maleki N, Barmettler G, Moulton EA, Scrivani S, Veggeberg R, Spierings EL, Burstein R, Becerra L, Borsook D.

Pain. 2015 Jul;156(7):1232-9. doi: 10.1097/j.pain.0000000000000159.

49.

Pharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda.

Masters SH, Burstein R, DeCenso B, Moore K, Haakenstad A, Ikilezi G, Achan J, Osei I, Garshong B, Kisia C, Njuguna P, Babigumira J, Kumar S, Hanlon M, Gakidou E.

PLoS One. 2014 Dec 11;9(12):e114762. doi: 10.1371/journal.pone.0114762. eCollection 2014.

50.

Association of statin use and risk for severe headache or migraine by serum vitamin D status: a cross-sectional population-based study.

Buettner C, Burstein R.

Cephalalgia. 2015 Aug;35(9):757-66. doi: 10.1177/0333102414559733. Epub 2014 Nov 25.

PMID:
25424706

Supplemental Content

Loading ...
Support Center